Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?

Capricor Therapeutics (CAPR) shares ended the last trading session 20.4% higher at $9.25. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 25.1% loss over the past four weeks.Capricor recorded a strong price increase after it provided regulatory updates related to its Biologics License Application (BLA) for Deramiocel, the company’s lead cell therapy candidate for the treatment of Duchenne Muscular Dystrophy—associa ...